Ambulatory Cardiac Monitoring Solution

[INQ. NO. 2309E25] HUINNO Co., Ltd. is a healthcare-wearables startup developing digital healthcare solutions with patented and KFDA-approved wearables with patient-monitoring technologies, based on its excellent AI-based cloud analytics software.
HUINNO offers reports and dashboards to healthcare professionals, helping them make informed clinical decisions.

Product/Service
MEMO is an AI-based analytic solution that makes it easy to detect arrhythmias by continuously monitoring ECG for up to 14 days.
MEMO analyzes ECG data with AI to show arrhythmias and compares them to the patient’s normal rhythms, providing a complete picture of heart hearth.
MEMO makes ECG monitoring easier and more accessible, so you can take charge of your heart health and make informed decisions about your care.

High patient acceptance
HUINNO conducted a clinical trial with 150 participants at the Korea University Anam Hospital and the Bundang Seoul National University. The patients who underwent testing for 14 days (336 hours) showed actual wear time of 12 days or more, with an adherence rate of 89.2%.
1st place for 6 & 4 lead ECGs at the Global AI Challenge, PhysioNet
Team HUINNO ranked first in 6/4 lead part and second in 2/3/12 lead part with outstanding results in the global AI Challenge, PhysioNet ECG analysis competition sponsored by Harvard Medical School and MIT.
Establishment of a high-quality ECG dataset Through close cooperation with Seoul National University Hospital and other leading general hospitals, HUINNO has accumulated over 750,000 ECG data measured from actual patients over six years.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods